Clinical Trial Update: Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing primary tumor ablation outcomes in metastatic renal cell carcinoma treated with immunotherapy combinations; the study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Renal Cell Cancer, Kidney Neoplasm | Phase 4 | Status: RECRUITING